Intrathecal drug delivery (IDD) is an innovative approach ... and advancements in IDD systems, highlighting their potential benefits for patients who do not respond well to conventional pain ...

Trial registration International Standard Randomised Controlled Trials Centre (ISRCTN 33733462). Recent systematic reviews were unable to find randomised controlled trials evaluating the effectiveness ...

The blood–brain barrier is the biggest challenge to the development of drugs that target the CNS. Most capillary beds leak plasma contents between and across endothelial cells by way of window-like ...

Drug delivery describes the method and approach ... Here the authors develop an extended release naloxone prodrug delivery system and report the preclinical testing in rat and cynomolgus monkey ...

That's important, as Zolgensma is the world's most expensive drug, costing more than $2.1 million for a one-shot dose. Intrathecal delivery could kickstart sales of Zolgensma, which have taken a ...

intending to bring to market an innovative targeted drug delivery system that uses – you guessed it – milk. The pair have committed to using their milk-based tech to treat both common and rare ...

Nanomedicine. 2012;7(8):1253-1271. Liposomes Liposomes are self-assembled artificial vesicles developed from amphiphilic phospholipids. These vesicles consist of a spherical bilayer structure ...

intrathecal delivery of therapeutics into the spinal canal or subarachnoid space of the brain, and the use of nanoparticles to improve drug delivery. Lilly's involvement will add a new dimension ...

3. Increased Scrutiny On The Environmental Impact Of Healthcare Is Likely To Drive Companies To Invest More In The Development Of Sustainability-Focused Device Systems . Reducing the environmental ...

Department of Biological Science and Technology, Center for Intelligent Drug Systems and Smart Bio-devices (IDS 2 B), National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan Department of ...

Insmed is set to challenge the Duchenne muscular dystrophy (DMD) treatment space with its innovative gene therapy asset, ...